TP53 and colorectal cancer: Thus, there is a strong demand for the development of novel colorectal cancer therapeutics, and the p53 pathway is an attractive therapeutic target for colorectal cancer, because p53 functions as the most efficient barrier to caner development and progression of its prominent role in cell cycle arrest and cell death [9,10].